Argos Therapeutics, Inc. to Present at the Sachs Cancer Bio Partnering Forum

Published: May 20, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, N.C., May 20, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Doug Plessinger, Vice President of Clinical and Medical Affairs, is scheduled to present at the Sachs Cancer Bio Partnering Forum at the Westin Copley Place in Boston.

Help employers find you! Check out all the jobs and post your resume.

Back to news